Alzheimer’s Disease/Dementia News

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health issues, recent data suggest they may improve brain health.

The FDA approved 16 psychiatric drugs over the last decade, most of which shared similar mechanisms of action with previously developed drugs, according to data in a research latter published in JAMA Network Open.

A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and subsequently for assisting clinicians in formulating a treatment plan for patients, according to new research.

Older adults with Alzheimer’s disease and related dementias faced a greater risk for hospitalization after being continuously exposed to extreme heat, results from a cohort study showed.

Prolonged rapid eye movement sleep latency may be an early indicator of Alzheimer’s disease and related dementias, according to research conducted in China and published in Alzheimer’s & Dementia.

Tracking lipid variability may be a reliable method of predicting dementia and cognitive decline among community-dwelling older adults, according to new research from Neurology.

Black individuals in the U.S. with serious illnesses receive disproportionately poor pain management and health care communication, compared with white individuals, a focus group led by the Center to Advance Palliative Care showed.

Four out of five older adults who likely have dementia may be unaware of their condition, according to findings from a cohort study published in the Journal of General Internal Medicine.

An interpretive machine learning model may be a feasible method for measuring agitation in dementia as well as in predicting certain environmental factors that are likely to contribute to the condition, according to a study.